Clinical Report: Guiding Kidney-Sparing Approaches in Upper Tract Urothelial Carcinoma
Overview
This report discusses the role of liquid biopsy in the management of upper tract urothelial carcinoma (UTUC), emphasizing its potential in preoperative risk assessment and perioperative monitoring. Liquid biopsy should complement traditional diagnostic methods.
Background
Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5-10% of urothelial cancers. Accurate preoperative risk stratification is crucial for determining appropriate treatment, particularly in preserving renal function. Current methods for assessing tumor biology are limited.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
Liquid biopsy can provide noninvasive detection and preoperative triage for UTUC.
Plasma circulating tumor DNA (ctDNA) is linked to biological upstaging and perioperative risk refinement.
Current evidence supports liquid biopsy as an adjunct to traditional imaging and pathology methods.
Kidney-sparing surgery (KSS) is increasingly considered for selected low-risk UTUC cases.
Accurate patient selection for KSS is critical.
Clinical Implications
Healthcare professionals should consider the role of liquid biopsy in the preoperative assessment of UTUC, while utilizing traditional diagnostic methods.
Conclusion
Liquid biopsy presents a promising adjunct in the management of UTUC, aiding in risk assessment and monitoring while emphasizing the importance of comprehensive evaluation in treatment planning.
